FindTrial
Sign In

Feasibility study on Mobile app based reporting the side effects of medicines given for TB in Government TB hosptals

Acceptability and feasibility of Mobile app in Adverse Drug Reactions(ADRs) reporting in Revised National Tuberculosis Control Program(RNTCP) centres

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035163
Enrollment
50
Registered
2021-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ADR Reporting by Mobile APP: Medical Officers will be trained on reporting ADR using mobile app namely PVPI ADR app developed by Govt of India, and will be asked to use it for Adverse

Sponsors

Director General ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria Medical Officers treating patients- 1.Suffering from TB 2. Enrolled at RNTCP centres in Madurai and Chennai districts 3. On Anti-Tuberculous Therapy(ATT)

Exclusion criteria

Exclusion criteria: Research subjects Unwilling to participate

Design outcomes

Primary

MeasureTime frame
1. Change in number of ADR reporting per Medical Officer in study RNTCP centres 2. Presence of absence of the mobile app in the mobile phone of Medical Officers in study RNTCP centres 3. Recording of NIL ADRs by the Medical Officers in study RNTCP centres after the study period. Timepoint: Baseline, 3rd month, 6th,9th and 12 monthly—

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable—

Countries

India

Contacts

Public ContactDr S Ramesh Kumar

ICMR- National Institute for Research in Tuberculosis

drrameshskumar@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026